GlassScriptPhysician profile
Jonathan M Lenzen
NPI 1275502510
$2,261.70
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $177 · 2021: $553 · 2022: $591 · 2023: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.75 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $831.96 | 2020-2023 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $357.94 | 2019-2023 | Arexvy, Trelegy Ellipta, Nucala |
| Sunovion Pharmaceuticals INC. | $249.42 | 2019-2020 | |
| Grifols USA, LLC | $220.74 | 2021-2023 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $172.90 | 2022-2023 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.52 | 2020-2023 | Spiriva Respimat, Stiolto Respimat |
| Mallinckrodt Hospital Products INC. | $60.71 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $46.95 | 2023 | Purified Cortrophin Gel |
| Mylan Specialty L.P. | $42.08 | 2021-2023 | Yupelri |
| Insmed, INC. | $40.77 | 2022-2023 | Arikayce |
| Baxter Healthcare | $39.90 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Pfizer INC. | $34.95 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $21.62 | 2021 | |
| Adma Biomanufacturing LLC | $20.39 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.65 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.20 | 2022 | |
| Vapotherm INC | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lenzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.